Prognostic factors are more important for overall survival (OS) than treatment outcome in patients with metastatic breast cancer (MBC). - Schmid,P.; Wischnewsky,M.B.; Sezer,O.; Pape,W.; Possinger,K. (Ann Oncol, 2000)